Hyaluronic Acid Herbal Extract
GET A QUOTE REQUEST MSDS
Get A Quote
List
1

Popular searches

Recommended products

Guanidine Carbonate
050-000-001 Dihydromyricetin
050-000-207 Triptolide
020-000-118 Micro Hyaluronic Acid (Micro HA), Super Active
020-000-275 Methacrylated Hyaluronic Acid (HAMA)
  • Home
  • Pharmaceuticals
  • (Discontinued) 040-000-291 Sulfadiazine, CAS 68-35-9

    • SKIP TO

    (Discontinued) 040-000-291 Sulfadiazine, CAS 68-35-9

    (0)
    Write a review

    About This Item

    Catalog No.
    040-000-291

    Discontinued

    Synonyms 2-sulfanilamidopyrimidine; 2-sulfanilylaminopyrimidine; 4-amino-N-2-pyrimidinylbenzenesulfonamide; N(1)-2-Pyrimidinylsulfanilamide; N(1)-2-Pyrimidylsulfanilamide; Sulfadiazin
    Keywords Antibiosis, epidemic meningitis, upper respiratory infection (URI), intestinal infection
    Related products Sulfacetamide Sodium Salt

    Quantity

    kg
    Inquiry Add to cart

    Technical Service

    Need help? Our team of experienced scientists is here for you.
    Contact us

    Description

    Sulfadiazine Specifications


    Product Name ‎Sulfadiazine
    CAS Registry Number 68-35-9
    Molecular Formula C₁₀H₁₀N₄O₂S
    Molecular Weight 250.28 g/mol
    Purity >99.0 %
    Appearance White powder
    Shelf life >2 years
    Functions Sulfonamide antibiotic. Antibacterial Sulfadiazine eliminates bacteria that cause infections by stopping the production of folate inside the bacterial cell, and is commonly used to treat urinary tract infections

    Sulfadiazine Description


    Sulfadiazine is one of the short-acting sulfonamides used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.

    Sulfadiazine is an antibiotic that fights bacteria.

    Sulfadiazine is used to treat many different types of infection, such as urinary tract infections, ear infections, meningitis, malaria, toxoplasmosis, and others.

    [caption id="attachment_7488" align="alignnone" width="365"]sulfadiazine sulfadiazine[/caption]

    Sulfadiazine Applications


    • For the treatment of rheumatic fever and meningococcal meningitis

    Reference:


    1. Hamilton, Richart (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. p. 104.
    2. Natural and synthetic polymers for wounds and burns dressing. Mogosanu GD and Grumezescu AM International Journal of Pharmaceutics 463(2), 127-136, (2014)
    3. Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns Stanford, W, et al. The Journal of Trauma and Acute Care Surgery 9(5), 377-388, (1969)

    Reviews

    5 Stars
    2
    4 Stars
    0
    3 Stars
    0
    2 Stars
    0
    1 Stars
    0
    Write a review

    Related Products

    Guanidine Carbonate
    Inquiry Add to List
    Sumatriptan Succinate
    Inquiry Add to List
    Allantoin
    Inquiry Add to List
    (R)-Amino-(4-hydroxyphenyl)acetic acid methyl ester hydrochloride
    Inquiry Add to List
    D(-)-4-Hydroxyphenylglycine
    Inquiry Add to List
    Potassium (R)-[(3-ethoxy-1-methyl-3-oxoprop-1-enyl)amino]phenylacetate
    Inquiry Add to List

    Write a Review

    Name
    E-mail
    Rating
    Review

    Get a Quote

    Send us an inquiry now to find out more information and the latest prices, thanks!
    Product Name
    Quantity
    Name
    Email
    Phone
    Company
    Application
    Country
    United States
    • United States
    • Afghanistan
    • Aland Islands
    • Albania
    • Algeria
    • American Samoa
    • Andorra
    • Angola
    • Anguilla
    • Antarctica
    • Antigua and Barbuda
    • Argentina
    • Armenia
    • Aruba
    • Australia
    • Austria
    • Azerbaijan
    • Bahamas
    • Bahrain
    • Bangladesh
    • Barbados
    • Belarus
    • Belgium
    • Belize
    • Benin
    • Bermuda
    • Bhutan
    • Bolivia
    • Bosnia and Herzegovina
    • Botswana
    • Bouvet Island
    • Brazil
    • British Indian Ocean Territory
    • British Virgin Islands
    • Brunei
    • Bulgaria
    • Burkina Faso
    • Burundi
    • Cambodia
    • Cameroon
    • Canada
    • Cape Verde
    • Cayman Islands
    • Central African Republic
    • Chad
    • Chile
    • China
    • Christmas Island
    • Cocos (Keeling) Islands
    • Colombia
    • Comoros
    • Congo
    • Cook Islands
    • Costa Rica
    • Croatia
    • Cuba
    • Cyprus
    • Czech Republic
    • Democratic Republic of Congo
    • Denmark
    • Disputed Territory
    • Djibouti
    • Dominica
    • Dominican Republic
    • East Timor
    • Ecuador
    • Egypt
    • El Salvador
    • Equatorial Guinea
    • Eritrea
    • Estonia
    • Ethiopia
    • Falkland Islands
    • Faroe Islands
    • Federated States of Micronesia
    • Fiji
    • Finland
    • France
    • French Guyana
    • French Polynesia
    • French Southern Territories
    • Gabon
    • Gambia
    • Georgia
    • Germany
    • Ghana
    • Gibraltar
    • Greece
    • Greenland
    • Grenada
    • Guadeloupe
    • Guam
    • Guatemala
    • Guinea
    • Guinea-Bissau
    • Guyana
    • Haiti
    • Heard Island and Mcdonald Islands
    • Honduras
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Iran
    • Iraq
    • Iraq-Saudi Arabia Neutral Zone
    • Ireland
    • Israel
    • Italy
    • Ivory Coast
    • Jamaica
    • Japan
    • Jordan
    • Kazakhstan
    • Kenya
    • Kiribati
    • Kuwait
    • Kyrgyzstan
    • Laos
    • Latvia
    • Lebanon
    • Lesotho
    • Liberia
    • Libya
    • Liechtenstein
    • Lithuania
    • Luxembourg
    • Macau
    • Macedonia
    • Madagascar
    • Malawi
    • Malaysia
    • Maldives
    • Mali
    • Malta
    • Marshall Islands
    • Martinique
    • Mauritania
    • Mauritius
    • Mayotte
    • Mexico
    • Moldova
    • Monaco
    • Mongolia
    • Montenegro
    • Montserrat
    • Morocco
    • Mozambique
    • Myanmar
    • Namibia
    • Nauru
    • Nepal
    • Netherlands Antilles
    • Netherlands
    • New Caledonia
    • New Zealand
    • Nicaragua
    • Niger
    • Nigeria
    • Niue
    • Norfolk Island
    • North Korea
    • Northern Mariana Islands
    • Norway
    • Oman
    • Pakistan
    • Palau
    • Palestinian Territories
    • Panama
    • Papua New Guinea
    • Paraguay
    • Peru
    • Philippines
    • Pitcairn Islands
    • Poland
    • Portugal
    • Puerto Rico
    • Qatar
    • Reunion
    • Romania
    • Russia
    • Rwanda
    • Saint Helena and Dependencies
    • Saint Kitts and Nevis
    • Saint Lucia
    • Saint Pierre and Miquelon
    • Saint Vincent and the Grenadines
    • Samoa
    • San Marino
    • Sao Tome and Principe
    • Saudi Arabia
    • Senegal
    • Serbia
    • Seychelles
    • Sierra Leone
    • Singapore
    • Slovakia
    • Slovenia
    • Solomon Islands
    • Somalia
    • South Africa
    • South Georgia and South Sandwich Islands
    • South Korea
    • Spain
    • Spratly Islands
    • Sri Lanka
    • Sudan
    • Suriname
    • Svalbard and Jan Mayen
    • Swaziland
    • Sweden
    • Switzerland
    • Syria
    • Taiwan
    • Tajikistan
    • Tanzania
    • Thailand
    • Togo
    • Tokelau
    • Tonga
    • Trinidad and Tobago
    • Tunisia
    • Turkey
    • Turkmenistan
    • Turks And Caicos Islands
    • Tuvalu
    • US Virgin Islands
    • Uganda
    • Ukraine
    • United Arab Emirates
    • United Kingdom
    • United States
    • United States Minor Outlying Islands
    • Uruguay
    • Uzbekistan
    • Vanuatu
    • Vatican City
    • Venezuela
    • Vietnam
    • Wallis and Futuna
    • Western Sahara
    • Yemen
    • Zambia
    • Zimbabwe
    Comments
    I would like to join the mailing list to receive updates from Stanford Optics.
    Check Code